透過您的圖書館登入
IP:3.15.141.206
  • 學位論文

將3D-QSAR技術應用在以配體為基準的farnesly轉移脢抑制劑的分子模擬研究

A ligand-based molecular modeling study on some farnesyltransferase inhibitors by several 3D-QSAR techniques

指導教授 : 林志侯
若您是本文的作者,可授權文章由華藝線上圖書館中協助推廣。

摘要


以一系列總共37個farnesly轉移脢抑制劑為基礎,經由CoMFA,COMSIA,Catalyst程式建立了數個三維空間定量結構活性關係。farnesly轉移脢被認為在與Ras有關的癌症生成中扮演重要角色。由一個farnesly轉移脢的晶體結構當作模板來建立其餘的抑制劑三維結構。這群結構分別被分為訓練組,21個,以及測試組16個來進行CoMFA,CoMSIA以及Catalyst的分析。Catalyst部份則由最佳的CoMSIA結果來選擇使用的結構特性。這些結果皆被套回farnesly轉移脢的活性區,也討論了從CoMSIA來選擇Catalyst要使用的結構特性之可行性。經由此篇CoMFA,CoMSIA以及Catalyst的結果相信可以增加找到更有潛力的抗癌抑制劑的可能性。

關鍵字

分子模擬 轉移脢 抑制劑

並列摘要


無資料

並列關鍵字

pharmacophore 3D QSAR farnesyltransferase CoMFA CoMSIA Catalyst

參考文獻


1. Reid, T. S.; Beese, L. S., Crystal structures of the anticancer clinical candidates R115777 (Tipifarnib) and BMS-214662 complexed with protein farnesyltransferase suggest a mechanism of FTI selectivity. Biochemistry 2004, 43, (22), 6877-84.
2. Santagada, V.; Caliendo, G.; Severino, B.; Lavecchia, A.; Perissutti, E.; Fiorino, F.; Zampella, A.; Sepe, V.; Califano, D.; Santelli, G.; Novellino, E., Synthesis, pharmacological evaluation, and molecular modeling studies of novel peptidic CAAX analogues as farnesyl-protein-transferase inhibitors. J Med Chem 2006, 49, (6), 1882-90.
4. Appels, N. M.; Beijnen, J. H.; Schellens, J. H., Development of farnesyl transferase inhibitors: a review. Oncologist 2005, 10, (8), 565-78.
5. Selleri C, M. J., Montuori N, et al., Involvement of nitric oxide in farnesyltransferase inhibitor-mediated apoptosis in chronic myeloid leukemia cells. Blood 2003, 102, 1490–8.
6. She M, P. I., Sun L, Yeung SC., Enhancement of manumycin A-induced apoptosis by methoxyamine in myeloid leukemia cells. Leukemia 2005, (19), 595–602.

延伸閱讀